Questa pagina è stata tradotta automaticamente e l'accuratezza della traduzione non è garantita. Si prega di fare riferimento al Versione inglese per un testo di partenza.

Feasibility of a 4-Week Intensive Postoperative Multimodal Rehabilitation Program in Complicated Patients After Proximal Pancreatectomy: A Prospective Single-Cohort Study (REACT)

14 agosto 2026 aggiornato da: Nicolò Pecorelli, IRCCS San Raffaele

The REACT study is a prospective, single-center, single-cohort study designed to evaluate the feasibility of a 4-week intensive multimodal postoperative rehabilitation program in patients who develop severe complications after proximal pancreatic resection (pancreatoduodenectomy or total pancreatectomy).

Postoperative complications after pancreatic surgery may result in substantial physiological and metabolic stress, leading to loss of muscle mass, malnutrition, reduced functional capacity, and delayed recovery. Although prehabilitation programs have been proposed to improve patients' functional capacity before surgery, evidence regarding structured multimodal rehabilitation after pancreatic surgery is currently lacking.

Adult patients undergoing elective proximal pancreatic resection who develop a severe postoperative complication (Comprehensive Complication Index >21) will be eligible for the study. Participants will undergo a 4-week multimodal rehabilitation program starting after hospital discharge and including individualized exercise training, nutritional therapy, and anxiety-reducing techniques. The program may be delivered either in a supervised hospital-based setting or through a home-based program according to patient preference and availability.

The primary objective is to assess the feasibility of the rehabilitation program in terms of recruitment, adherence, completion of outcome assessments, completeness of data, and safety. Secondary objectives include evaluating postoperative functional recovery using PROMIS-29 Physical and Mental Health Summary Scores, the 6-minute walk test, and the Duke Activity Status Index. In patients with malignancy who are candidates for adjuvant treatment, return to intended oncologic treatment will also be evaluated.

A total of 40 patients will be enrolled and followed for up to 90 days after surgery.

Panoramica dello studio

Stato

Non ancora reclutamento

Condizioni

Intervento / Trattamento

Descrizione dettagliata

Pancreatic surgery is associated with a high rate of postoperative morbidity. Postoperative complications may impose substantial physiological and metabolic stress, leading to depletion of functional reserves, loss of muscle mass and energy stores, malnutrition, sarcopenia, and reduced functional capacity. Recovery may be particularly prolonged in patients experiencing severe postoperative complications and in frail patients with limited physiological and metabolic reserves. Although multimodal prehabilitation has been proposed to improve functional capacity before major surgery, evidence supporting the role of structured multimodal rehabilitation in improving recovery after pancreatic resection is currently lacking.

REACT is a prospective, single-center, single-cohort, low-interventional clinical study conducted at IRCCS Ospedale San Raffaele, Milan, Italy. The study is designed to evaluate the feasibility of a 4-week intensive multimodal postoperative rehabilitation program in patients who develop severe complications after proximal pancreatic resection. All enrolled participants will receive the multimodal rehabilitation intervention in addition to standard postoperative care; no formal comparator group is included.

The study population will include adult patients undergoing elective proximal pancreatic resection, defined as pancreatoduodenectomy or total pancreatectomy, who develop a severe postoperative complication during their hospital stay, defined according to a Comprehensive Complication Index (CCI) >21.

The multimodal rehabilitation program will start during the first week after postoperative hospital discharge and will last 4 weeks. The intervention includes exercise training, nutritional therapy, and anxiety-reducing techniques and will be individualized according to the patient's physical, nutritional, psychological, and clinical condition. Activities will be performed under the supervision of qualified healthcare professionals, including physiotherapists, nutritionists, and psychology-trained personnel.

The exercise component will include endurance, resistance, and breathing exercises tailored to the individual patient's clinical condition. Endurance training will consist of progressively increasing moderate-intensity continuous training, with intensity adjusted according to patient performance and perceived exertion using the Borg scale. Resistance exercises will involve different upper- and lower-limb muscle groups, with progressive workload adjustments based on individual performance. The program will include two to three supervised training sessions per week, with a minimum frequency of three exercise sessions per week specified for the overall program.

Exercise rehabilitation may be delivered either in a hospital-based or home-based setting according to patient preference and availability. Hospital-based exercise sessions will be conducted in the hospital gym. For patients following the home-based program, the hospital-based intervention will be adapted while maintaining the same overall duration, therapeutic goals, and monitoring approach. Outdoor walking may replace treadmill- or cycle-based aerobic exercise when equipment is unavailable, while resistance exercises will be performed using resistance bands provided by the study center. Educational materials, video demonstrations, and monitoring devices will be provided when appropriate.

The nutritional component will consist of an individualized dietary management plan based on dietary habits, medical conditions, and nutritional status. A balanced food-based intervention will be prescribed to meet estimated caloric and nutritional requirements. A daily protein intake of 1.5-2.0 g/kg of ideal body weight will be recommended, and whey protein supplementation may be prescribed when needed. Participants will also receive instruction on anxiety-reducing strategies, including imagery, visualization, and deep-breathing techniques.

The primary objective of the study is to assess the feasibility of the 4-week multimodal rehabilitation program. Feasibility will be evaluated according to five predefined criteria: at least 50% of eligible patients agree to participate; at least 80% of enrolled patients adhere to the program; at least 80% of participants complete an outcome assessment after rehabilitation; the proportion of missing data among patients completing outcome assessments is below 10%; and no serious adverse events related to the rehabilitation program occur. The intervention will be considered feasible only if all five predefined criteria are met.

Adherence will be defined as completion of at least 80% of the planned intervention components, including exercise sessions, nutritional consultations, and psychological support sessions. For hospital-based rehabilitation, adherence will be documented by the rehabilitation team, while adherence to the home-based program will be assessed using patient diaries reviewed during regular telephone contacts. An exploratory subgroup analysis will compare feasibility outcomes between hospital-based and home-based rehabilitation.

Secondary objectives will evaluate functional recovery following surgery. Outcomes will include the Patient-Reported Outcomes Measurement Information System-29 (PROMIS-29) Physical Health Summary Score and Mental Health Summary Score, the 6-minute walk test (6MWT), and the Duke Activity Status Index (DASI). Recovery will be assessed in relation to preoperative values and predefined minimal important differences. Assessments will be performed preoperatively, at hospital discharge, at the end of the 4-week rehabilitation program, and 90 days after surgery. In patients with malignancy who are candidates for adjuvant treatment, time to return to intended oncologic treatment (RIOT) will also be evaluated.

Safety will be assessed by monitoring, recording, and analyzing adverse events occurring during the study, with particular attention to events potentially related to exercise training, nutritional intervention, or psychological support. Routine clinical assessments performed as part of standard postoperative care will also contribute to the safety evaluation.

The planned sample size is 40 participants. Assuming an expected adherence rate of 80%, this sample size allows adherence to be estimated with a 95% confidence interval of approximately ±12 percentage points and is considered appropriate for the pilot feasibility objective of the study. Enrollment is planned over 12 months, the rehabilitation intervention will last 4 weeks, and participants will be followed for up to 3 months.

Tipo di studio

Interventistico

Iscrizione (Stimato)

40

Fase

  • Non applicabile

Contatti e Sedi

Questa sezione fornisce i recapiti di coloro che conducono lo studio e informazioni su dove viene condotto lo studio.

Contatto studio

Criteri di partecipazione

I ricercatori cercano persone che corrispondano a una certa descrizione, chiamata criteri di ammissibilità. Alcuni esempi di questi criteri sono le condizioni generali di salute di una persona o trattamenti precedenti.

Criteri di ammissibilità

Età idonea allo studio

  • Adulto
  • Adulto più anziano

Accetta volontari sani

No

Descrizione

  • Inclusion Criteria:
  • Age ≥18 years.
  • Patients undergoing elective proximal pancreatic resection (pancreatoduodenectomy or total pancreatectomy).
  • Patients developing a severe postoperative complication during their hospital stay, defined as a Comprehensive Complication Index (CCI) >21.
  • Exclusion Criteria:
  • Metastatic disease.
  • Surgical procedures other than pancreatoduodenectomy or total pancreatectomy.
  • Inability to speak Italian.
  • Cognitive impairment or illiteracy resulting in inability to read and understand the Italian language.
  • Medical conditions contraindicating the rehabilitation regimen (exercise and nutritional intervention), including orthopedic or cognitive disabilities and chronic renal failure (dialysis or creatinine >250 mmol).
  • Pregnancy.

Piano di studio

Questa sezione fornisce i dettagli del piano di studio, compreso il modo in cui lo studio è progettato e ciò che lo studio sta misurando.

Come è strutturato lo studio?

Dettagli di progettazione

  • Scopo principale: Trattamento
  • Assegnazione: N / A
  • Modello interventistico: Assegnazione di gruppo singolo
  • Mascheramento: Nessuno (etichetta aperta)

Armi e interventi

Gruppo di partecipanti / Arm
Intervento / Trattamento
Sperimentale: Multimodal Postoperative Rehabilitation
Participants will receive a 4-week intensive multimodal postoperative rehabilitation program starting during the first week after hospital discharge. The program includes individualized exercise training, nutritional therapy, and anxiety-reducing techniques, tailored to each participant's clinical, physical, nutritional, and psychological condition. Exercise training will be delivered either in a supervised hospital-based setting or through a home-based program according to patient preference and availability. All participants will receive the multimodal rehabilitation program in addition to standard care
Participants will undergo a 4-week multimodal postoperative rehabilitation program starting during the first week after hospital discharge. The program includes individualized exercise training, nutritional therapy, and anxiety-reducing techniques. Exercise includes moderate-intensity endurance, resistance, and breathing exercises tailored to the patient's clinical condition and may be delivered in a hospital-based or home-based setting. Nutritional therapy consists of an individualized dietary plan, with a recommended protein intake of 1.5-2.0 g/kg of ideal body weight and whey protein supplementation if needed. Participants will also receive instruction in relaxation techniques, including imagery, visualization, and deep-breathing exercises. The program is delivered by qualified physiotherapists, nutritionists, and psychology-trained personnel.

Cosa sta misurando lo studio?

Misure di risultato primarie

Misura del risultato
Misura Descrizione
Lasso di tempo
Feasibility of the multimodal postoperative rehabilitation program
Lasso di tempo: At the end of the 4-week rehabilitation program

Feasibility will be assessed according to five predefined criteria:

  1. ≥50% of eligible patients agree to participate;
  2. ≥80% of enrolled patients adhere to the program;
  3. ≥80% complete the post-rehabilitation outcome assessment;
  4. missing data among patients completing outcome assessments are <10%; (5) no serious adverse events related to the rehabilitation program occur.

The intervention will be considered feasible only if all five criteria are met.

At the end of the 4-week rehabilitation program

Misure di risultato secondarie

Misura del risultato
Misura Descrizione
Lasso di tempo
PROMIS-29 Physical Health Summary Score recovery
Lasso di tempo: At hospital discharge, at the end of the 4-week rehabilitation program, and 90 days after surgery
Proportion of participants who recover their preoperative PROMIS-29 Physical Health Summary Score (PHS) or show a decline smaller than the minimal important difference (MID) of 2.3 points.
At hospital discharge, at the end of the 4-week rehabilitation program, and 90 days after surgery
PROMIS-29 Mental Health Summary Score recovery
Lasso di tempo: At hospital discharge, at the end of the 4-week rehabilitation program, and 90 days after surgery
Proportion of participants who recover their preoperative PROMIS-29 Mental Health Summary Score (MHS) or show a decline smaller than the minimal important difference (MID) of 2.3 points.
At hospital discharge, at the end of the 4-week rehabilitation program, and 90 days after surgery
Six-Minute Walk Test recovery
Lasso di tempo: At hospital discharge, at the end of the 4-week rehabilitation program, and 90 days after surgery
Proportion of participants who recover their preoperative 6-minute walk test (6MWT) performance or show a decline smaller than the minimal important difference of 19 meters.
At hospital discharge, at the end of the 4-week rehabilitation program, and 90 days after surgery
Duke Activity Status Index recovery
Lasso di tempo: At hospital discharge, at the end of the 4-week rehabilitation program, and 90 days after surgery
Proportion of participants who recover their preoperative Duke Activity Status Index (DASI) or show a decline smaller than the minimal important difference of 6 METs.
At hospital discharge, at the end of the 4-week rehabilitation program, and 90 days after surgery

Collaboratori e investigatori

Qui è dove troverai le persone e le organizzazioni coinvolte in questo studio.

Sponsor

Studiare le date dei record

Queste date tengono traccia dell'avanzamento della registrazione dello studio e dell'invio dei risultati di sintesi a ClinicalTrials.gov. I record degli studi e i risultati riportati vengono esaminati dalla National Library of Medicine (NLM) per assicurarsi che soddisfino specifici standard di controllo della qualità prima di essere pubblicati sul sito Web pubblico.

Studia le date principali

Inizio studio (Stimato)

1 settembre 2026

Completamento primario (Stimato)

31 marzo 2027

Completamento dello studio (Stimato)

31 marzo 2028

Date di iscrizione allo studio

Primo inviato

11 agosto 2026

Primo inviato che soddisfa i criteri di controllo qualità

14 agosto 2026

Primo Inserito (Effettivo)

17 agosto 2026

Aggiornamenti dei record di studio

Ultimo aggiornamento pubblicato (Effettivo)

17 agosto 2026

Ultimo aggiornamento inviato che soddisfa i criteri QC

14 agosto 2026

Ultimo verificato

1 agosto 2026

Maggiori informazioni

Termini relativi a questo studio

Altri numeri di identificazione dello studio

  • REACT

Piano per i dati dei singoli partecipanti (IPD)

Hai intenzione di condividere i dati dei singoli partecipanti (IPD)?

INDECISO

Informazioni su farmaci e dispositivi, documenti di studio

Studia un prodotto farmaceutico regolamentato dalla FDA degli Stati Uniti

No

Studia un dispositivo regolamentato dalla FDA degli Stati Uniti

No

Queste informazioni sono state recuperate direttamente dal sito web clinicaltrials.gov senza alcuna modifica. In caso di richieste di modifica, rimozione o aggiornamento dei dettagli dello studio, contattare register@clinicaltrials.gov. Non appena verrà implementata una modifica su clinicaltrials.gov, questa verrà aggiornata automaticamente anche sul nostro sito web .